2016
DOI: 10.1007/s12028-016-0316-0
|View full text |Cite
|
Sign up to set email alerts
|

Volume of Plasma Expansion and Functional Outcomes in Stroke

Abstract: The present study demonstrates an association between greater volume of plasma expansion and worse neurological recovery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2019
2019

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…In a secondary analysis of the data from the Albumin in Acute Stroke Part 2 trial (ALIAS 2), Miller et al investigated the relationship between the magnitude of overall intravenous volume infusion over the first 48 h and the clinical outcome at day 90. Although this study did not focus on LHS and the period of controlled volume application appears rather short, they found an association between a greater volume of plasma expansion and a worse neurological recovery (26). On the other hand, dehydration represents a well-established risk factor for poor outcome after ischaemic stroke.…”
Section: Discussionmentioning
confidence: 76%
“…In a secondary analysis of the data from the Albumin in Acute Stroke Part 2 trial (ALIAS 2), Miller et al investigated the relationship between the magnitude of overall intravenous volume infusion over the first 48 h and the clinical outcome at day 90. Although this study did not focus on LHS and the period of controlled volume application appears rather short, they found an association between a greater volume of plasma expansion and a worse neurological recovery (26). On the other hand, dehydration represents a well-established risk factor for poor outcome after ischaemic stroke.…”
Section: Discussionmentioning
confidence: 76%
“…Pilot data from [32] strongly support the link between CO and cerebral perfusion, and are the basis for this group’s recently reported clinical trial design [33], the results of which we eagerly await. Conversely, the risks of volume therapy without CO guidance are suggested by a secondary analysis of the Albumin in Acute Stroke Part 2 (ALIAS 2) trial [34]. This analysis found that larger strokes, and higher NIHSS scores, were associated with larger volumes of fluid.…”
Section: Targeting Fluid Therapymentioning
confidence: 99%